Washington Trust CO Amgen Inc Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Washington Trust CO holds 46,228 shares of AMGN stock, worth $12.3 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

46,228

Previous 46,959 1.56%

Holding current value

$12.3 Million

Previous $14.7 Million 1.52%

% of portfolio

0.53%

Previous 0.54%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $226,156 - $246,624	-731 Reduced 1.56%	46,228 $14.9 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $369,426 - $448,949	-1,406 Reduced 2.91%	46,959 $14.7 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $24,467 - $29,534	91 Added 0.19%	48,365 $13.8 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $49,861 - $56,249	-195 Reduced 0.4%	48,274 $13.9 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $77,620 - $96,368	-355 Reduced 0.73%	48,469 $13 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $53,138 - $62,835	-248 Reduced 0.51%	48,824 $10.8 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $11 Million - $13.4 Million	48,535 Added 99051.02%	48,584 $11.7 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $11.1 Million - $13.5 Million	-49,023 Reduced 99.9%	49 $11.7 Million
Q4 2022 Jul 27, 2023	BUY	$229.03 - $291.01 $111,766 - $142,012	488 Added 1.0%	49,072 $12.9 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $467,221 - $593,660	-2,040 Reduced 3.99%	49,072 $12.9 Million
Q3 2022 Oct 14, 2022	SELL	$224.46 - $253.15 $122,106 - $137,713	-544 Reduced 1.05%	51,112 $11.5 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $191,258 - $212,837	-829 Reduced 1.58%	51,656 $12.6 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $639,610 - $707,576	2,917 Added 5.88%	52,485 $12.7 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $56,084 - $64,183	-282 Reduced 0.57%	49,568 $11.2 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $5,094 - $5,968	24 Added 0.05%	49,850 $10.6 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $82,920 - $91,994	355 Added 0.72%	49,826 $12.1 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $242,991 - $283,167	1,095 Added 2.26%	49,471 $12.3 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $62,101 - $73,951	287 Added 0.6%	48,376 $11.1 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $64,294 - $71,500	-274 Reduced 0.57%	48,089 $12.2 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $268,625 - $329,640	1,358 Added 2.89%	48,363 $11.2 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $155,815 - $206,653	-855 Reduced 1.79%	47,005 $9.53 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $82,306 - $105,792	435 Added 0.92%	47,860 $11.5 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $19,326 - $23,156	111 Added 0.23%	47,425 $10.1 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $75,848 - $88,911	455 Added 0.97%	47,314 $8.72 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $616,585 - $695,026	-3,409 Reduced 6.78%	46,859 $8.07 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $3,211 - $3,748	-18 Reduced 0.04%	50,268 $9.79 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $442,843 - $499,247	-2,390 Reduced 4.54%	50,286 $10.4 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $29,058 - $32,639	175 Added 0.33%	52,676 $9.72 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $95,389 - $111,474	-563 Reduced 1.06%	52,501 $8.95 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $129,630 - $144,837	768 Added 1.47%	53,064 $9.23 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $8.75 Million - $9.99 Million	52,296	52,296 $9.75 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Amgen Inc Transaction History